-
1
-
-
0036372173
-
Angiotensin II suppression in humans by the orally active renin inhibitor Alis-kiren (SPP100): Comparison with enalapril
-
Nussberger J, Wuerzner G, Jensen C, Brunner HR: Angiotensin II suppression in humans by the orally active renin inhibitor Alis-kiren (SPP100): Comparison with enalapril. Hypertension 39: E1-E8, 2002
-
(2002)
Hypertension
, vol.39
-
-
Nussberger, J.1
Wuerzner, G.2
Jensen, C.3
Brunner, H.R.4
-
2
-
-
60549087324
-
Long-term antihypertensive efficacy and safety of the oral direct renin inhibitor aliskiren: A 12-month randomized, double-blind comparator trial with hydrochlorothiazide
-
Schmieder RE, Philipp T, Guerediaga J, Gorostidi M, Smith B, Weissbach N, Maboudian M, Botha J, van Ingen H: Long-term antihypertensive efficacy and safety of the oral direct renin inhibitor aliskiren: A 12-month randomized, double-blind comparator trial with hydrochlorothiazide. Circulation 119: 417-425, 2009
-
(2009)
Circulation
, vol.119
, pp. 417-425
-
-
Schmieder, R.E.1
Philipp, T.2
Guerediaga, J.3
Gorostidi, M.4
Smith, B.5
Weissbach, N.6
Maboudian, M.7
Botha, J.8
van Ingen, H.9
-
3
-
-
14844363404
-
Aliskiren, a novel orally effective renin inhibitor, provides dose-dependent antihypertensive efficacy and placebolike tolerability in hypertensive patients
-
Gradman AH, Schmieder RE, Lins RL, Nussberger J, Chiang Y, Bedigian MP: Aliskiren, a novel orally effective renin inhibitor, provides dose-dependent antihypertensive efficacy and placebolike tolerability in hypertensive patients. Circulation 111: 1012-1018, 2005
-
(2005)
Circulation
, vol.111
, pp. 1012-1018
-
-
Gradman, A.H.1
Schmieder, R.E.2
Lins, R.L.3
Nussberger, J.4
Chiang, Y.5
Bedigian, M.P.6
-
4
-
-
44849114597
-
AVOID Study Investigators: Aliskiren combined with losartan in type 2 diabetes and nephropathy
-
Parving HH, Persson F, Lewis JB, Lewis EJ, Hollenberg NK; AVOID Study Investigators: Aliskiren combined with losartan in type 2 diabetes and nephropathy. N Engl J Med 358: 2433-2446, 2008
-
(2008)
N Engl J Med
, vol.358
, pp. 2433-2446
-
-
Parving, H.H.1
Persson, F.2
Lewis, J.B.3
Lewis, E.J.4
Hollenberg, N.K.5
-
5
-
-
79958249630
-
Aliskiren Observation of Heart Failure Treatment (ALOFT) Investigators: Effects of the oral direct renin inhibitor aliskiren in patients with symptomatic heart failure
-
McMurray JJ, Pitt B, Latini R, Maggioni AP, Solomon SD, Keefe DL, Ford J, Verma A, Lewsey J; Aliskiren Observation of Heart Failure Treatment (ALOFT) Investigators: Effects of the oral direct renin inhibitor aliskiren in patients with symptomatic heart failure. Circ Heart Fail 1: 17-24, 2008
-
(2008)
Circ Heart Fail
, vol.1
, pp. 17-24
-
-
McMurray, J.J.1
Pitt, B.2
Latini, R.3
Maggioni, A.P.4
Solomon, S.D.5
Keefe, D.L.6
Ford, J.7
Verma, A.8
Lewsey, J.9
-
6
-
-
47049089844
-
Clinical pharmacokinetics and pharmacodynamics of aliskiren
-
Vaidyanathan S, Jarugula V, Dieterich HA, Howard D, Dole WP: Clinical pharmacokinetics and pharmacodynamics of aliskiren. Clin Pharmacokinet 47: 515-531, 2008
-
(2008)
Clin Pharmacokinet
, vol.47
, pp. 515-531
-
-
Vaidyanathan, S.1
Jarugula, V.2
Dieterich, H.A.3
Howard, D.4
Dole, W.P.5
-
7
-
-
39849089447
-
Comparative efficacy and safety of aliskiren, an oral direct renin inhibitor, and ramipril in hypertension: A 6-month, randomized, double-blind trial
-
Andersen K, Weinberger MH, Egan B, Constance CM, Ali MA, Jin J, Keefe DL: Comparative efficacy and safety of aliskiren, an oral direct renin inhibitor, and ramipril in hypertension: A 6-month, randomized, double-blind trial. J Hypertens 26: 589-599, 2008
-
(2008)
J Hypertens
, vol.26
, pp. 589-599
-
-
Andersen, K.1
Weinberger, M.H.2
Egan, B.3
Constance, C.M.4
Ali, M.A.5
Jin, J.6
Keefe, D.L.7
-
8
-
-
33947182655
-
Aliskiren, an oral renin inhibitor, provides dose-dependent efficacy and sustained 24-hour blood pressure control in patients with hypertension
-
Oh BH, Mitchell J, Herron JR, Chung J, Khan M, Keefe DL: Aliskiren, an oral renin inhibitor, provides dose-dependent efficacy and sustained 24-hour blood pressure control in patients with hypertension. J Am Coll Cardiol 49: 1157-1163, 2007
-
(2007)
J Am Coll Cardiol
, vol.49
, pp. 1157-1163
-
-
Oh, B.H.1
Mitchell, J.2
Herron, J.R.3
Chung, J.4
Khan, M.5
Keefe, D.L.6
-
9
-
-
46449118638
-
Effects of aliskiren on blood pressure, albuminuria, and (pro)renin receptor expression in diabetic TG (mRen-2)27 rats
-
Feldman DL, Jin L, Xuan H, Contrepas A, Zhou Y, Webb RL, Mueller DN, Feldt S, Cumin F, Maniara W, Persohn E, Schuetz H, Jan Danser AH, Nguyen G: Effects of aliskiren on blood pressure, albuminuria, and (pro)renin receptor expression in diabetic TG (mRen-2)27 rats. Hypertension 52: 130-136, 2008
-
(2008)
Hypertension
, vol.52
, pp. 130-136
-
-
Feldman, D.L.1
Jin, L.2
Xuan, H.3
Contrepas, A.4
Zhou, Y.5
Webb, R.L.6
Mueller, D.N.7
Feldt, S.8
Cumin, F.9
Maniara, W.10
Persohn, E.11
Schuetz, H.12
Jan-Danser, A.H.13
Nguyen, G.14
-
10
-
-
47049093197
-
Renal and hormonal responses to direct renin inhibition with aliskiren in healthy humans
-
Fisher ND, Jan Danser AH, Nussberger J, Dole WP, Hollenberg NK: Renal and hormonal responses to direct renin inhibition with aliskiren in healthy humans. Circulation 117: 3199-3205, 2008
-
(2008)
Circulation
, vol.117
, pp. 3199-3205
-
-
Fisher, N.D.1
Jan-Danser, A.H.2
Nussberger, J.3
Dole, W.P.4
Hollenberg, N.K.5
-
11
-
-
0842285725
-
FAIR true-FISP perfu-sion imaging of the kidneys
-
Martirosian P, Klose U, Mader I, Schick F: FAIR true-FISP perfu-sion imaging of the kidneys. Magn Reson Med 51: 353-361, 2004
-
(2004)
Magn Reson Med
, vol.51
, pp. 353-361
-
-
Martirosian, P.1
Klose, U.2
Mader, I.3
Schick, F.4
-
12
-
-
77950190399
-
Measurement of kidney perfusion by magnetic resonance imaging: Comparison of MRI with arterial spin labeling to para-aminohippuric acid plasma clearance in male subjects with metabolic syndrome
-
Ritt M, Janka R, Schneider MP, Martirosian P, Hornegger J, Bautz W, Uder M, Schmieder RE: Measurement of kidney perfusion by magnetic resonance imaging: comparison of MRI with arterial spin labeling to para-aminohippuric acid plasma clearance in male subjects with metabolic syndrome. Nephrol Dial Transplant 25: 1126-1133, 2010
-
(2010)
Nephrol Dial Transplant
, vol.25
, pp. 1126-1133
-
-
Ritt, M.1
Janka, R.2
Schneider, M.P.3
Martirosian, P.4
Hornegger, J.5
Bautz, W.6
Uder, M.7
Schmieder, R.E.8
-
13
-
-
57449100853
-
Aliskiren accumulates in Renin secretory granules and binds plasma prorenin
-
Krop M, Garrelds IM, de Bruin RJ, van Gool JM, Fisher ND, Hollenberg NK, Jan Danser AH: Aliskiren accumulates in Renin secretory granules and binds plasma prorenin. Hypertension 52: 1076-1083, 2008
-
(2008)
Hypertension
, vol.52
, pp. 1076-1083
-
-
Krop, M.1
Garrelds, I.M.2
de Bruin, R.J.3
van Gool, J.M.4
Fisher, N.D.5
Hollenberg, N.K.6
Jan-Danser, A.H.7
-
14
-
-
59849101131
-
Aliskiren therapy will have minimal effect on in-tracellular renin of renin-producing cells
-
Campbell DJ: Aliskiren therapy will have minimal effect on in-tracellular renin of renin-producing cells. Hypertension 53: e17, 2009
-
(2009)
Hypertension
, vol.53
-
-
Campbell, D.J.1
-
15
-
-
78649927683
-
Arterial spin labeling MRI for assessment of perfusion in native and transplanted kidneys
-
Artz NS, Sadowski EA, Wentland AL, Grist TM, Seo S, Djamali A, Fain SB: Arterial spin labeling MRI for assessment of perfusion in native and transplanted kidneys. Magn Reson Imaging 29: 74- 82, 2011
-
(2011)
Magn Reson Imaging
, vol.29
, pp. 74-82
-
-
Artz, N.S.1
Sadowski, E.A.2
Wentland, A.L.3
Grist, T.M.4
Seo, S.5
Djamali, A.6
Fain, S.B.7
-
16
-
-
69849112971
-
Comparative effects of aliskiren-based and ramipril-based therapy on the renin system during long-term (6 months) treatment and withdrawal in patients with hypertension
-
Andersen K, Weinberger MH, Constance CM, Ali MA, Jin J, Prescott MF, Keefe DL: Comparative effects of aliskiren-based and ramipril-based therapy on the renin system during long-term (6 months) treatment and withdrawal in patients with hypertension. J Renin Angiotensin Aldosterone Syst 10: 157-167, 2009
-
(2009)
J Renin Angiotensin Aldosterone Syst
, vol.10
, pp. 157-167
-
-
Andersen, K.1
Weinberger, M.H.2
Constance, C.M.3
Ali, M.A.4
Jin, J.5
Prescott, M.F.6
Keefe, D.L.7
-
17
-
-
9644287897
-
Pharmacologic demonstration of the synergistic effects of a combination of the renin inhibitor aliskiren and the AT1 receptor antagonist valsartan on the an-giotensin II-renin feedback interruption
-
Azizi M, Ménard J, Bissery A, Guyenne TT, Bura-Riviére A, Vaidyanathan S, Camisasca RP: Pharmacologic demonstration of the synergistic effects of a combination of the renin inhibitor aliskiren and the AT1 receptor antagonist valsartan on the an-giotensin II-renin feedback interruption. J Am Soc Nephrol 15: 3126-3133, 2004
-
(2004)
J Am Soc Nephrol
, vol.15
, pp. 3126-3133
-
-
Azizi, M.1
Ménard, J.2
Bissery, A.3
Guyenne, T.T.4
Bura-Riviére, A.5
Vaidyanathan, S.6
Camisasca, R.P.7
-
18
-
-
79953238880
-
Intra-tubular renin-angiotensin system in hypertension
-
Navar LG, Kobori H, Prieto MC, Gonzalez-Villalobos RA: Intra-tubular renin-angiotensin system in hypertension. Hypertension 57: 355-362, 2011
-
(2011)
Hypertension
, vol.57
, pp. 355-362
-
-
Navar, L.G.1
Kobori, H.2
Prieto, M.C.3
Gonzalez-Villalobos, R.A.4
-
19
-
-
59849103597
-
Urinary angiotensinogen as a novel biomarker of the intrarenal renin-angiotensin system status in hypertensive patients
-
Kobori H, Alper AB, Shenava R, Katsurada A, Saito T, Ohashi N, Urushihara M, Miyata K, Satou R, Hamm LL, Navar LG: Urinary angiotensinogen as a novel biomarker of the intrarenal renin-angiotensin system status in hypertensive patients. Hypertension 53: 344-350, 2009
-
(2009)
Hypertension
, vol.53
, pp. 344-350
-
-
Kobori, H.1
Alper, A.B.2
Shenava, R.3
Katsurada, A.4
Saito, T.5
Ohashi, N.6
Urushihara, M.7
Miyata, K.8
Satou, R.9
Hamm, L.L.10
Navar, L.G.11
-
20
-
-
77954386389
-
Urinary angiotensinogen is correlated with blood pressure in men (Bogalusa Heart Study)
-
Kobori H, Urushihara M, Xu JH, Berenson GS, Navar LG: Urinary angiotensinogen is correlated with blood pressure in men (Bogalusa Heart Study). J Hypertens 28: 1422-1428, 2010
-
(2010)
J Hypertens
, vol.28
, pp. 1422-1428
-
-
Kobori, H.1
Urushihara, M.2
Xu, J.H.3
Berenson, G.S.4
Navar, L.G.5
|